We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+8.2%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$82.1B
AUM Growth
+$7.21B
Cap. Flow
+$2.14B
Cap. Flow %
2.6%
Top 10 Hldgs %
34.14%
Holding
3,101
New
616
Increased
843
Reduced
896
Closed
659

Top Sells

Rank Stock Value
1
COST icon
Costco
COST
+$495M
2
SPOT icon
Spotify
SPOT
+$377M
3
HUM icon
Humana
HUM
+$350M
4
GS icon
Goldman Sachs
GS
+$324M
5
MRK icon
Merck
MRK
+$307M

Sector Composition

Rank Sector Weight
1 Technology 18.11%
2 Consumer Discretionary 14.61%
3 Healthcare 12.89%
4 Industrials 6.78%
5 Financials 6.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SOXX icon
1101
iShares Semiconductor ETF
SOXX
$42B
$3.59M ﹤0.01%
+15,564
New +$3.58M
ATEX icon
1102
Anterix
ATEX
$1.81B
$3.59M ﹤0.01%
95,291
+36,639
+62% +$1.41M
CNP icon
1103
CenterPoint Energy
CNP
$28.9B
$3.59M ﹤0.01%
+121,966
New +$3.41M
DBRG icon
1104
DigitalBridge
DBRG
$2.94B
$3.59M ﹤0.01%
+253,805
New +$3.37M
IYR icon
1105
iShares US Real Estate ETF
IYR
$4.75B
$3.57M ﹤0.01%
35,089
+23,332
+198% +$2.25M
TRML
1106
DELISTED
Tourmaline Bio
TRML
$3.55M ﹤0.01%
138,194
-32,253
-19% -$538K
CDRE icon
1107
Cadre Holdings
CDRE
$1.4B
$3.55M ﹤0.01%
93,479
-68,292
-42% -$2.44M
AAON icon
1108
Aaon
AAON
$8.22B
$3.55M ﹤0.01%
32,875
+18,990
+137% +$1.73M
GRAL
1109
GRAIL Inc
GRAL
$2.88B
$3.53M ﹤0.01%
256,265
+175,319
+217% +$2.66M
ELVN icon
1110
Enliven Therapeutics
ELVN
$3.92B
$3.52M ﹤0.01%
138,006
-54,094
-28% -$1.25M
RPAY icon
1111
Repay Holdings
RPAY
$331M
$3.52M ﹤0.01%
431,674
+302,411
+234% +$2.67M
UNH icon
1112
PUT
UnitedHealth
UNH
$380B
$3.51M ﹤0.01%
6,000
+5,900
+5,900% +$3.34M
EXTR icon
1113
Extreme Networks
EXTR
$3.86B
$3.49M ﹤0.01%
232,305
+208,876
+892% +$2.96M
TNK icon
1114
Teekay Tankers
TNK
$2.62B
$3.48M ﹤0.01%
59,790
-113,106
-65% -$6.67M
BLMN icon
1115
Bloomin' Brands
BLMN
$712M
$3.48M ﹤0.01%
+210,236
New +$3.73M
RBRK icon
1116
Rubrik
RBRK
$15.4B
$3.47M ﹤0.01%
107,832
-64,928
-38% -$2.15M
NTR icon
1117
Nutrien
NTR
$32.2B
$3.46M ﹤0.01%
72,070
-208,915
-74% -$10.1M
WLDN icon
1118
Willdan Group
WLDN
$1.1B
$3.46M ﹤0.01%
84,563
+6,453
+8% +$232K
GOSS icon
1119
Gossamer Bio
GOSS
$74.1M
$3.45M ﹤0.01%
3,484,932
+149,421
+4% +$144K
IESC icon
1120
IES Holdings
IESC
$12.1B
$3.44M ﹤0.01%
17,247
+12,713
+280% +$2.06M
VMC icon
1121
Vulcan Materials
VMC
$37.2B
$3.42M ﹤0.01%
+13,665
New +$3.39M
HRTX icon
1122
Heron Therapeutics
HRTX
$88.1M
$3.41M ﹤0.01%
1,715,545
-45,506
-3% -$109K
SOXX icon
1123
CALL
iShares Semiconductor ETF
SOXX
$42B
$3.41M ﹤0.01%
14,800
+1,800
+14% +$413K
BORR
1124
Borr Drilling
BORR
$1.28B
$3.4M ﹤0.01%
618,531
-762,930
-55% -$4.67M
KGC icon
1125
Kinross Gold
KGC
$28.6B
$3.39M ﹤0.01%
+362,437
New +$3.25M

Similar funds

Marshall Wace's Q3 2024 Portfolio in Review

As of Q3 2024, Marshall Wace held 3,101 positions worth $82.1B, up 9.6% from $74.9B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Marshall Wace's Q3 2024 filing shows 616 new, 843 increased, 896 reduced and 659 closed positions. Its largest new stake was Texas Instruments: 1,008,812 shares worth $208M. The largest sale was Costco, an estimated $495M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Marshall Wace's largest Q3 2024 buy was Texas Instruments: 1,008,812 shares worth $208M.
  • Marshall Wace added most to Tesla in Q3 2024, an estimated $700M increase.
  • Marshall Wace's biggest Q3 2024 reduction was Costco, cutting an estimated $495M.
  • Marshall Wace fully exited Shopify in Q3 2024, selling an estimated $209M.
  • Marshall Wace's ten largest holdings make up 34% of its $82.1B portfolio in Q3 2024.
  • Marshall Wace opened 616 new positions and closed 659 in Q3 2024.
  • Marshall Wace's portfolio value rose 9.6% quarter-over-quarter to $82.1B.

Based on Marshall Wace's 13F filing for Q3 2024, filed 14 Nov 2024.